AstraZeneca says Tagrisso + Orpathys safety profile unchanged
AstraZeneca says the Tagrisso plus Orpathys safety profile is consistent with known profiles and that it has found no new safety findings.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.